You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CPD

Identifying Severe Asthma in Primary Care Practice and When to Refer

  • Authors: Hilary Pinnock, MD; Jaime Correia de Sousa, MD, MSc, PhD; Catalina Panaitescu, MD
  • CPD Released: 9/27/2019; Reviewed and Renewed: 2/4/2021
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 2/4/2022
Start Activity


Target Audience and Goal Statement

This educational activity is intended for an international audience of non-US primary care physicians, pulmonologists, and allergists & clinical immunologists, involved in the management of asthma.

The goal of this activity is to increase knowledge on the assessment of patients with uncontrolled asthma in order to improve competence in early identification and referral of severe asthma patients.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Key differences between "difficult to manage" and severe asthma in terms of patient evaluation and disease management
    • Guideline recommendations on implementing inhaled and oral therapies for asthma
  • Have greater competence related to
    • Diagnosing and referring all patients with severe asthma to specialist care (ie, pulmonologists or allergists)


Disclosures

WebMD Global requires each individual who is in a position to control the content of one of its educational activities to disclose any relevant financial relationships occurring within the past 12 months that could create a conflict of interest.


Moderator

  • Hilary Pinnock, MD

    Family Physician
    Professor of Primary Care Respiratory Medicine
    Usher Institute of Population Health Sciences and Informatics
    University of Edinburgh
    Edinburgh, UK

    Disclosures

    Disclosure: Hilary Pinnock, MD, has disclosed no relevant financial relationships. 

Faculty

  • Catalina Panaitescu, MD

    Family Physician
    Co-coordinator of the Romanian Primary Care Respiratory Group RespiRO
    Bucarest, Romania

    Disclosures

    Disclosure: Catalina Panaitescu, MD, has disclosed no relevant financial relationships. 

  • Jaime Correia de Sousa, MD, MSc, PhD

    Associate Professor
    School of Health Sciences
    University of Minho
    Minho, Portugal

    Disclosures

    Disclosure: Jaime Correia de Sousa, MD, MsC, PhD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline
    Served as a speaker or a member of a speakers bureau for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.

Steering Committee

  • Chair

    Ioanna Tsiligianni, MD, has disclosed the following relevant financial relationships:

    Served as an advisor or consultant for: AstraZeneca; Boehringer Ingelheim Pharmaceuticals, Inc.; GlaxoSmithKline; Novartis Pharmaceuticals Corporation

    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation

    Received grants for clinical research from: GlaxoSmithKline Greece

    Steering Committee Members
    Luis Alves, MD
    Assistant Professor of Family Medicine
    Institute for Biomedical Sciences Abel Salazar
    University of Porto
    Porto, Portugal

    Luis Alves, MD, has disclosed the following relevant financial relationships:

    Served as an advisor or consultant for: AstraZeneca; GlaxoSmithKline

    Served as a speaker or a member of a speakers bureau for: Novartis Pharmaceuticals Corporation

    Luke Daines, MD
    General Practitioner
    Clinical Academic Fellow
    University of Edinburgh
    Edinburgh, United Kingdom

    Luke Daines, MD, has disclosed the following relevant financial relationships:

    Received grants for clinical research from: Asthma UK; Innovate UK

Editor

  • Walid Amara, MD

    Scientific Director, WebMD Global, LLC

    Disclosures

    Disclosure: Walid Amara, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: BIOTRONIK; SERVIER
    Served as a speaker or a member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Boehringer Ingelheim Pharmaceuticals, Inc.; Boston Scientific; Bristol-Myers Squibb Company; Livanova; MEDA; Medtronic, Inc.; MSD; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Physiomed; St. Jude, SERVIER

Content Reviewer

  • Esther Nyarko, PharmD

    Associate Clinical CME Director 

    Disclosures

    Disclosure: Esther Nyarko, PharmD, has disclosed no relevant financial relationships.


Accreditation Statements

    For Physicians

  • The Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (FPM) has reviewed and approved the content of this educational activity and allocated it 0.50 continuing professional development credits (CPD).

    Contact WebMD Global

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information about your eligibility to claim credit, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent participating in the activity. To successfully earn credit, participants must complete the activity online during the credit eligibility period that is noted on the title page.

Follow these steps to claim a credit certificate for completing this activity:

  1. Read the information provided on the title page regarding the target audience, learning objectives, and author disclosures, read and study the activity content and then complete the post-test questions. If you earn a passing score on the post-test and we have determined based on your registration profile that you may be eligible to claim CPD credit for completing this activity, we will issue you a CPD credit certificate.
  2. Once your CPD credit certificate has been issued, you may view and print the certificate from your CME/CE Tracker. CPD credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of the Medscape Education homepage.

We encourage you to complete an Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates by accessing "Edit Your Profile" at the top of your Medscape homepage.

*The credit that you receive is based on your user profile.

CPD

Identifying Severe Asthma in Primary Care Practice and When to Refer

Authors: Hilary Pinnock, MD; Jaime Correia de Sousa, MD, MSc, PhD; Catalina Panaitescu, MDFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CPD Released: 9/27/2019; Reviewed and Renewed: 2/4/2021

Valid for credit through: 2/4/2022

processing....

Insights From an Asthma Specialist

This commentary is part of a larger educational activity.  After participating, please return to  Identifying Severe Asthma in Primary Care Practice and When to Refer  to access all related educational content. 

« Return to: Identifying Severe Asthma in Primary Care Practice and When to Refer
  • Print